US4781601046 - Common Stock
154.35 -0.06 (-0.04%)
After market: 154.6 +0.25 (+0.16%)
JOHNSON & JOHNSON
NYSE:JNJ (5/26/2023, 7:04:00 PM)
After market: 154.6 +0.25 (+0.16%)154.35
-0.06 (-0.04%)
Find more stocks on New York Stock Exchange, Inc.
Find more stocks on the USA
Find competitors from the same sector on the USA
Find competitors from the same industry on the USA
Find stocks with similar TA and Setup ratings on the USA
Find stocks with similar Fundamental rating on the USA
Find the competitors with the best technical ratings on the USA
Find the competitors with the best technical and setup ratings on the USA
Find the competitors with the best fundamentals on the USA
Find the competitors with the best valuation on the USA
Find the competitors with the best dividend on the USA
Find the competitors with the best analyst ratings on the USA
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. The company is headquartered in New Brunswick, New Jersey and currently employs 152,700 full-time employees. The firm is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The company operates through three segments: Consumer Health, Pharmaceutical and MedTech. Its primary focus is products related to human health and well-being. The Consumer Health segment includes a range of products that is focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension. The MedTech segment includes a range of products used in the interventional solutions, orthopaedics, surgery, and vision fields. Its geographic area includes the United States, Europe, Western Hemisphere (excluding the United States), and Africa, Asia and Pacific.
JOHNSON & JOHNSON
One Johnson & Johnson Plaza
New Brunswick NEW JERSEY 08933
P: 17325242455.0
CEO: A. Gorsky
Employees: 152700
Website: https://www.jnj.com/
These top undervalued blue-chip stocks offer a significant amount of upside as we get into the second half of 2023.
You'll want to follow Buffett's lead and hold on to these stocks forever.
Spinoffs are nothing new for publicly traded companies, but with the way things have gone in 2023, it could be a banner year for healthcare spinoffs. Read more here.
(Bloomberg) -- Kenvue Inc., the consumer health business that Johnson & Johnson spun off this month, will be eligible for ratings from a slew of major Wall Street banks next week, offering a chance to see how analysts are assessing initial public offerings amid the latest equities volatility and recession worries. Most Read from BloombergEmerging US Debt Deal Would Raise Limit, Cap Spending for Two YearsCathie Wood’s ARKK Dumped Nvidia Stock Before $560 Billion SurgeEurope’s Economic Engine Is B
Kenvue Inc., the consumer health business that Johnson & Johnson spun off this month, will be eligible for ratings from a slew of major Wall Street banks next week, offering a chance to see how analysts are assessing initial public offerings amid the latest equities volatility and recession worries.
Here are some compelling Dow stocks to buy if you believe the market may be on the cusp of a relief rally this summer.
Here you can normally see the latest stock twits on JNJ, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: